Search Results - "Chung, Lau Y."

Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor by Yeung, Sai F, Tong, Joanna H M, Law, Peggy P W, Chung, Lau Y, Lung, Raymond W M, Tong, Carol Y K, Chow, Chit, Chan, Anthony W H, Wan, Innes Y P, Mok, Tony S K, To, Ka F

“…Oncogenic driver mutations activating receptor tyrosine kinase pathways are promising predictive markers for targeted treatment. We investigated the mutation…”
Get more information

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis by Tong, Joanna H, Yeung, Sai F, Chan, Anthony W H, Chung, Lau Y, Chau, Shuk L, Lung, Raymond Wai Ming, Tong, Carol Y, Chow, Chit, Tin, Edith K Y, Yu, Yau H, Li, Hui, Pan, Yi, Chak, Wing P, Ng, Calvin S H, Mok, Tony S K, To, Ka F

“…Activation of MET oncogene as the result of amplification or activation mutation represents an emerging molecular target for cancer treatment. We…”
Get full text

Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma by Chan, Anthony W. H., Tong, Joanna H. M., Kwan, Johnny S. H., Chow, Chit, Chung, Lau Y., Chau, Shuk L., Lung, Raymond W. M., Ng, Calvin S. H., Wan, Innes Y. P., Mok, Tony S. K., To, Ka F.

“…Immune checkpoint blockade targeting the PD-1/PD-L1 axis has recently demonstrated efficacy and promise in cancer treatment. Appropriate biomarker selection is…”
Get full text